| Symbol | WUXAY |
|---|---|
| Name | WUXI APPTEC CO LTD. |
| Sector | UNDEFINED |
| Region | Asia |
| Industry | - |
| Address | 200131 China 288 Fute Zhong Road Waigaoqiao Free Trade Zone |
| Telephone | +86 (21) 2066-3734 |
| Fax | — |
| — | |
| Website | https://www.wuxiapptec.com/ |
| Incorporation | CN |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Hong Kong Stock Exchange |
| CIK | 0001775585 |
| Description | WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The Company is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The Company mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment. Additional info from OTC: |
No news found.